1993PubMedRequires access

Assessment of autoantibodies to the zona pellucida in serum and follicular fluid in in-vitro fertilization patients.

Themis Mantzavinos, N Dalamanga, D. Hassiakos, Fotini Dimitriadou, S. Konidaris, P A Zourlas

Open publisher page 17 citations

Abstract

Eighty two consecutive IVF patients enrolled in our In-Vitro Fertilization program were investigated on the presence of anti-zona pellucida antibodies in the peripheral blood and follicular fluid, using a haemaglutination test (ovarian zona pellucida HAT) and a zona pellucida slide test, respectively. Overall higher proportion of antibody activity was observed in pregnant patients in both compartments (60% and 53%) in serum and follicular fluid, respectively) than the activity observed in non-pregnant (25% and 48%, respectively). There were no statistically significant differences found for the mean number of oocytes retrieved and fertilized irrespective of the presence of antibodies in serum or in follicular fluid, each one being taken into account separately. However, higher fertilization rates were observed in serum or follicular fluid antibody negative patients (68.2% and 71.2%, respectively) than those who were tested positive (36.6% and 65.4%, respectively). The same was true for the presence of anti-zona pellucida antibodies in serum and in follicular fluid, taking into consideration their presence or absence in both compartments simultaneously.

About this research paper

What this paper is about

Eighty two consecutive IVF patients enrolled in our In-Vitro Fertilization program were investigated on the presence of anti-zona pellucida antibodies in the peripheral blood and follicular fluid, using a haemaglutination test (ovarian zona pellucida HAT) and a zona pellucida slide test, respectively. Overall higher proportion of antibody activity was observed in pregnant patients in both compartments (60% and 53%) in serum and follicular fluid, respectively) than the activity observed in non-pregnant (25% and 48%, respectively). There were no statistically significant differences found for the mean number of oocytes retrieved and fertilized irrespective of the presence of antibodies in serum or in follicular fluid, each one being taken into account separately. However, higher fertilization rates were observed in serum or follicular fluid antibody negative patients (68.2% and 71.2%, respectively) than those who were tested positive (36.6% and 65.4%, respectively). The same was true for the presence of anti-zona pellucida antibodies in serum and in follicular fluid, taking into consideration their presence or absence in both compartments simultaneously.

Why it matters

OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Eighty two consecutive IVF patients enrolled in our In-Vitro Fertilization program were investigated on the presence of anti-zona pellucida antibodies in the peripheral blood and follicular fluid, using a haemaglutination test (ovarian zona pellucida HAT) and a zona pellucida slide test, respectively. Overall higher proportion of antibody activity was observed in pregnant patients in both compartments (60% and 53%) in serum and follicular fluid, respectively) than the activity observed in non-pregnant (25% and 48%, respectively). There were no statistically significant differences found for the mean number of oocytes retrieved and fertilized irrespective of the presence of antibodies in serum or in follicular fluid, each one being taken into account separately. However, higher fertilization rates were observed in serum or follicular fluid antibody negative patients (68.2% and 71.2%, respectively) than those who were tested positive (36.6% and 65.4%, respectively). The same was true for the presence of anti-zona pellucida antibodies in serum and in follicular fluid, taking into consideration their presence or absence in both compartments simultaneously.

Key concepts: Zona pellucida, Follicular fluid, Human fertilization, Follicular phase, In vitro fertilisation, Medicine, Andrology, Antibody

Related papers

Back to paper searchBrowse research topicsOriginal source
Assessment of autoantibodies to the zona pellucida in serum and follicular fluid in in-vitro fertilization patients. — Research Paper | ScholarLens